Basic Information
DIOSynVax Custom Vaccine Antigen Design to Maximize Protection Against Existing and Future Viruses Globally. Based on viral structure and evolution, our patented approach combines computational biology with in vitro and in vivo validation to select optimal Vaccine Antigen Payload (VAP) candidates, while continuously expanding the database and improving our design.
DIOSynVax
Cambridge,England,United Kingdom
15~50 people
January 01, 2017
media@diosvax.com

